PDCD1 and diffuse large B-cell lymphoma: Analysis of 405 DLBCL cases revealed that a lack of T cells and/or NK cells, along with increased programmed cell-death 1 (PD-1) expression on immune cells, is associated with poor prognosis and correlates with the resistance to standard immunochemotherapy (8, 9).